AUTOIMMUNE HEPATITIS
Clinical trials for AUTOIMMUNE HEPATITIS explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEPATITIS trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial targets stubborn liver disease
Disease control CompletedThis study tested whether an experimental drug called VAY736 could help adults with autoimmune hepatitis whose current treatments aren't working well enough. Researchers compared different doses of VAY736 against a placebo in 68 patients over 24 weeks. The main goal was to see if…
Matched conditions: AUTOIMMUNE HEPATITIS
Phase: PHASE2, PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 23:50 UTC
-
New drug tested to tame rogue immune system attacking the liver
Disease control CompletedThis study tested whether adding an investigational drug called zetomipzomib to standard steroid therapy could better control autoimmune hepatitis. It involved 24 adults whose liver disease was still active despite standard care. Participants received weekly injections of either …
Matched conditions: AUTOIMMUNE HEPATITIS
Phase: PHASE2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Scientists test new scan to spot liver damage without a biopsy
Diagnosis CompletedThis study tested how reliable a special type of MRI scan, called LiverMultiScan, is for measuring liver health. Researchers scanned 61 adults with various liver conditions on different MRI machines to see if the results were consistent. The goal was to see if this scan could be …
Matched conditions: AUTOIMMUNE HEPATITIS
Sponsor: Perspectum • Aim: Diagnosis
Last updated Apr 03, 2026 14:41 UTC